Our solution

Pharmacogenomics — effectively integrated into patients’ everyday clinical care.

The OneOme RightMed® pharmacogenomic test


The OneOme RightMed test is a physician-ordered pharmacogenomic test that analyzes a patient’s DNA to determine how he or she may respond to certain medications. The analysis is provided to the physician in the form of a static and interactive report which clearly identifies which prescription drugs are — or aren’t — likely to work. This information can help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.

How people metabolize drugs

  • PM icon
    Poor metabolizer (PM)
    Metabolizes drugs much
    more slowly than normal.
  • IM icon
    Intermediate metabolizer (IM)
    Metabolizes more
    slowly than normal.
  • EM icon
    Normal metabolizer (NM)
    Metabolizes at a
    normal rate.
  • UM icon
    Ultrarapid metabolizer (UM)
    Metabolizes more
    quickly than normal.



Pharmacogenomics, the study of how an individual's genes affect his or her response to medications, examines metabolization as a major factor contributing to an individual's response to drugs. Knowing how a patient will metabolize, or break down, many drugs will help physicians determine which drugs may work for their patients and reduce the trial-and-error approach.

Depending on variations in a patient’s genes, that patient may break down a drug too slowly or too quickly. If the patient is a poor metabolizer of a given drug, he or she may be exposed to too much of it, which may result in an adverse drug reaction (ADR). If the patient is an ultrarapid metabolizer of a drug, he or she may not get enough to have any effect at all. Since genes don’t change with time, this patient will always be an ultrarapid metabolizer of that drug.

Physicians can use this information to determine optimal drugs and doses for their patients.

Co-developed by Mayo Clinic, the RightMed test is:

  • comprehensive icon
  • individualized icon
      INDIVIDUALIZED: Comprised of a patient’s genetic information, medication history, and drug-to-drug interactions
  • credible icon
  • actionable icon
  • accessible icon
      ACCESSIBLE: Affordable — offered at a low-cost, out-of-pocket expense
  • service icon
      CONVENIENT: Customized 24/7 logistics and customer support including expert medical, genetics, and pharmacology staff on call



Testing for today and tomorrow

OneOme brings clarity and insight into new and existing medications. OneOme’s RightMed PGx test may help with:

  • reactive icon
      CURRENT PRESCRIPTIONS (REACTIVELY): Physicians can get insight into why a patient might be experiencing adverse effects or is not experiencing the expected benefits from a drug they’re already taking
  • proactive icon
      PRESCRIPTION DECISIONS (PROACTIVELY): Before prescribing a new medication, physicians can leverage a patient’s PGx profile to make more informed decisions


Because DNA does not change with time, the OneOme RightMed PGx test may provide years of more accurate decision-making.

OneOme's process

OneOme’s RightMed pharmacogenomic test analyzes a patient’s genetic information through our curated clinical PGx knowledgebase to provide information on the individual patient’s PGx profile. The actionable results are delivered to the provider through a variety of decision support tools.

OneOme engine graphic OneOme engine graphic